Outsourcing

Jul 30, 2015
By BioPharm International Editors
Cytovance Biologics Inc. announces development and manufacturing deal with NeuroFx for stem-cell-derived cell-free therapy for strokes.
Jul 30, 2015
By BioPharm International Editors
CMC Biologics and River Vision Development announce manufacturing agreement for RV001, a monoclonal antibody to treat Grave’s orbitopathy.
Jul 29, 2015
Financial expectations for Baxter’s biopharma solutions arm will drop 10% as the result of a client’s decision to move its manufacturing in house.
Jul 15, 2015
By BioPharm International Editors
Evans Analytical Group expands into the pharmaceutical/biopharmaceutical industry with acquisition of ABC Laboratories.
Jul 06, 2015
By BioPharm International Editors
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable more consistent, cost effective production of antibody combinations.
Jul 01, 2015
By BioPharm International Editors
The addition of a new manufacturing line at Lonza’s Portsmouth, NH site enables Alexion to add dedicated product supply for 10 years.
Jun 30, 2015
BioPharm International
While all market signs are pointing up, memories of past setbacks may discourage from expanding capacity.
Jun 28, 2015
BioPharm International
The 12th Annual Report and Survey of Biomanufacturing is now available.
Jun 17, 2015
By BioPharm International Editors
A new SGS Life Science Services laboratory outside Paris is designed for bio/pharmaceutical quality control testing.
Jun 17, 2015
By BioPharm International Editors
Lonza’s planned facility will be used to develop and manufacture viral gene therapies and virally modified cell therapies